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Edited by Felix WielandAbstract We hypothesized that catecholamines through b-adre-
noceptor might modulate macrophage function. We showed that
isoproterenol concentration-dependently induced HO-1 produc-
tion through b1-but not b2-adrenoceptor. Production was in-
creased by forskolin and inhibited by pretreatment with the
PKA inhibitor, H-89. Furthermore, induction of HO-1 by iso-
proterenol eﬀectively protected RAW264.7 cells from eﬀects of
glucose oxidase treatment, which was abrogated either by HO-
1 inhibitor, ZnPP IX and b-adenoceptor antagonist, propranolol.
Thus, stimulation of HO-1 production through b1-adenoceptors,
and via the PKA pathways by isoproterenol, can enable
RAW264.7 cells to resist oxidant stress, suggesting that cate-
cholamine hormones may be necessary, at least, to maximize
defending role of macrophages.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Macrophages are among the ﬁrst cells of the host to con-
front microbes and are important eﬀector cells in the bodys in-
nate resistance to intracellular microbial pathogens. The
outcome of this initial encounter with an intracellular patho-
gen is that either the macrophage resists the growth of the
microorganism or the microorganism adapts and replicates
within the macrophage. The ability of the macrophage to resist
the growth of the microorganism is dependent on the activa-
tion state of the macrophage. Cytokines, such as interferon
gamma (IFN-c), granulocyte-macrophage colony-stimulating
factor and tumor necrosis factor alpha, activate macrophagesAbbreviations: AR, adrenergic receptor; GOX, glucose oxidase; HO,
heme oxygenase; IFN-c, interferon gamma; PKA, protein kinase A;
ROS, reactive oxygen species; RT-PCR, reverse transcription poly-
merase chain reaction; TBS-T, tris–buﬀered saline/Tween 20; ZnPP,
zinc protoporphyrin
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doi:10.1016/j.febslet.2005.08.080to resist the growth of intracellular pathogens by enhancing
the production of the major antimicrobial eﬀector
molecules, including reactive oxygen species (ROS) and nitric
oxide [1–3].
On the other hand, the sympathetic nervous system acts to
maintain homeostasis during periods of stress by releasing
norepinephrine at sympathetic nerve endings, and epinephrine
from the adrenal medulla [4,5]. These catecholamine hor-
mones modulate the activities of cells, including those of the
immune system [6]. Macrophage function can be either acti-
vated [7–9] or suppressed [10–13] by catecholamines. Boomer-
shine et al. [14] showed that the addition of epinephrine to
IFN-c-activated mouse peritoneal macrophages inhibited the
ability of the macrophages to resist the growth of Mycobacte-
rium avium. This eﬀect was mediated by the b2-adrenergic
receptor and was correlated with a decrease in nitric oxide
production. In contrast, when resting peritoneal macrophages
were treated with epinephrine, the inhibition of mycobacte-
rial growth increased, suggesting that in this situation the
catecholamine activated the macrophages [7]. Macrophage
activation was mediated by a2-adrenergic stimulation; thus,
the a2-adrenergic agonist (a2-agonist) clonidine increased the
ability of the macrophages to inhibit mycobacterial growth,
and the eﬀect of epinephrine was blocked by the a-adrenergic
antagonist phentolamine. However, it is unclear how acti-
vated macrophages defend themselves from the reactive
ROS they produce.
Heme oxygenase (HO)-1 is now recognized as a beneﬁcial
molecule in protecting against the oxidative stresses induced
by many stimuli [15,16]. However, regulation of the activity
of the gene for ho-1 in macrophages under stress conditions
is not fully understood. While HO-1 production is induced
by stress [17,18], recent evidence suggests that increased intra-
cellular cAMP levels induce HO-1 production via a protein ki-
nase A (PKA)-dependent pathway [19,20]. Intracellular cAMP
levels are increased by several receptor-dependent pathways
including b-adrenoceptor-agonists.
We hypothesized that HO-1 may protect macrophages from
oxidant stresses as in other cells, in which catecholamines
through b-adrenoceptors play an important role for the induc-
tion of this enzyme. Therefore, the purpose of this study was to
explore the eﬀect of isoproterenol, one of the synthetic cate-
cholamines having b-adrenergic activity, on the production
of HO-1 in macrophages, the RAW264.7 cell line. In addition,
we investigated the mode of HO-1 induction and which
subtype of b-adrenergic receptor (AR) might be responsible
for it.ation of European Biochemical Societies.
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2.1. Materials
DMEM medium, fetal bovine serum, penicillin, streptomycin, and
glutamine were supplied by Gibco BRL (Rockville, MD). PRO-PREP
protein extract solution and ECL western blotting detection reagents
were supplied by iNtRON Biotechnology (Sungnam, Korea). MTT,
isoproterenol, propranolol, butoxamine, metoprolol, forskolin, H-89,
and RuCO were supplied by Sigma–Aldrich (St. Louis, MO). Glucose
oxidase (GOX) from Aspergillus niger and an anti-HO-1 antibody were
supplied by Santa Cruz Biotechnology (Santa Cruz, CA). Zinc proto-
porphyrin (ZnPP) IX was supplied by Calbiochem (La Jolla, CA).
2.2. Cell viability assay (MTT assay)
Cell viability was analyzed using the MTT assay. RAW264.7 cells at
the exponential growth phase were seeded at 104 cells/well in 24-well
plates. After diﬀerent treatments, 20 lL aliquots of 5 mg/mL MTT
solution was added to each well (0.1 mg/well) and incubated for 4 h.
Supernatants were aspirated and the formazan crystals in each well
were dissolved in 200 lL dimethyl sulfoxide (DMSO) for 30 min at
37 C and light absorbance at 570 nm was read on aMicroplate Reader
(Bio-Rad).
2.3. Western blotting
Cells were lysed in PRO-PREP protein extract solution. The sample
was centrifuged at 10000 · g for 20 min at 4 C. Protein concentration
was determined by the Bradford method. An equal volume of 2· SDS
sample buﬀer (0.1 M Tris–CI, 20% glycerol, 4% SDS and 0.01% bro-
mophenol blue) was added to an aliquot of the supernatant fraction
from the lysates and the mix was boiled for 5 min. Aliquots of 30 lg
of protein were subjected to 10% SDS–polyacrylamide gel electropho-
resis for 1 h 30 min at 110 V. The separated proteins were transferred
to PVDF membranes for 2 h at 20 mA with SD Semi-dry Transfer Cell
(Bio-Rad). The membranes were blocked with 5% nonfat milk in Tris–
buﬀed saline containing 0.05% Tween 20 (TBS-T) for 2 h at room tem-
perature. The membranes were then incubated with goat polyclonal
anti-mouse HO-1 at 1:500 concentration in 5% skim milk in TBS-T
overnight at 4 C, and bound antibody was detected by horseradish
peroxidase conjugated anti-goat IgG. The membranes were washed
and then developed using a Western Blotting Luminol Reagent system
and autoradiography.
2.4. HO activity
After incubation for various times, conﬂuent macrophages were
washed twice with phosphate-buﬀered saline, gently scraped oﬀ the
dish, and centrifuged (10000 · g, 5 min, 4 C). The cell pellet was sus-
pended in 2 mM MgCl2 phosphate buﬀer (100 mM, pH 7.4), frozen at
70 C, thawed three times and ﬁnally sonicated on ice before centri-
fugation at 13000 rpm for 15 min at 4 C. The supernatant (400 lL)
was added to a NADPH-generating system. This contained 0.8 mM
NADPH, 2 mM glucose-6-phosphate, 0.2 U glucose-6-phosphate-1-
dehydrogenase, and 2 mg protein of rat liver cytosol prepared from
the 105000 · g supernatant fraction as a source of biliverdin reductase,
potassium phosphate buﬀer (100 mM, pH 7.4), and hemin (10 lM) in a
ﬁnal volume of 200 lL. The reaction was incubated for 1 h at 37 C in
the dark and terminated by the addition of 600 lL chloroform. The ex-
tracted bilirubin was calculated from the diﬀerence in light absorption
between 464 and 530 nm wavelengths using a quartz cuvette. HO activ-
ity was measured as picomoles of bilirubin formed per milligram of
macrophage cell protein per hour.
2.5. Reverse transcription-polymerase chain reaction (RT-PCR) for
b-AR subtypes
Total RNA was extracted from the RAW264.7 cells by a single-
step guanidine thiocyanate–phenol–chloroform extraction procedure,
using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the
manufacturers instructions. RNA (2 lg) was reverse transcribed at
37 C for 90 min with 100 U of recombinant M-MLV reverse trans-
criptase in the presence of 0.1 lg DNA random hexamers, 40 U
RNase inhibitor, and 1.4 mM dNTPs in a ﬁnal volume of 50 lL.
The reaction was stopped by heating at 95 C for 5 min, then held
at 4 C for 5 min. A negative control without reverse transcriptase
was done to verify that ampliﬁcation did not ensue from residualgenomic DNA. PCR ampliﬁcation was carried out on cDNA equiv-
alent to 100 ng of starting mRNA, using speciﬁc oligonucleotide
primers for b1-AR (forward, 5 0-CATCGTAGTGGGCAACG-
TGTTG-3 0 and reverse, 5 0-AAATCGCAGCACTTGGGGTC-3 0),
for b2-AR (forward, 5 0-ACCTCCTTCTTGCCTATCCA-3 0 and
reverse, 5 0-TAGGTTTTCGAAGAAGACCG-3 0), and GAPDH
(forward, 5 0-ATCACCATCTTCCAGGAGCGAGA-3 0 and reverse,
5 0-CAAAGTTGTCATGGATGACCTT-3 0). The cDNA was heated
for 5 min at 95 C, then ampliﬁed using 35 cycles for b1-AR (94 C
for 1 min, 61 C for 1 min, 72 C for 2 min) and b2-AR (94 C for
1 min, 55 C for 1 min, 72 C for 2 min), and 25 cycles for GAPDH
(94 C for 30 s, 58 C for 30 s, 72 C for 45 s), followed by 5 min of
extension at 72 C. The PCR products were electrophoresed on 2%
ethidium bromide stained agarose gels.
2.6. DNA extraction and electrophoresis
The characteristic ladder pattern of DNA breakage caused by apop-
tosis was analyzed by agarose gel electrophoresis. Brieﬂy, DNA from
the RAW264.7 cells (3 · 106 cells per group) was isolated by a Geno-
mic DNA extraction kit (iNtRON Biotechnology, Sungnam, Korea).
Isolated genomic DNA was subjected to 1.5% agarose electrophoresis
at 100 V for 1 h. DNA was visualized by staining with ethidium bro-
mide under UV light.
2.7. Statistical evaluation
Values are expressed as means ± S.E.Ms. Diﬀerences from the
respective control for each experimental test condition were assessed
using paired Students t-tests, and P < 0.05 was assumed signiﬁcant.3. Results
3.1. Eﬀect of isoproterenol on HO-1 gene expression in
RAW264.7cells
There is abundant evidence that HO-1 is a stress-response
enzyme with cytoprotective eﬀects, including pulmonary de-
fense against LPS and hypoxia. To assess the role of isoprote-
renol for induction of HO-1 gene expression, murine
macrophage cell line RAW264.7 cells were treated for 6 h with
isoproterenol at doses of 1–200 lM. Western blot analysis
showed that there was no measurable induction of HO-1 pro-
tein production by isoproterenol at doses between 1 and
10 lM, but it was evident at doses of 50 lM or higher
(Fig. 1A). Treatment with 100 lM of isoproterenol increased
HO-1 levels in a time-dependent manner (Fig. 1B).
3.2. Induction of HO-1 production through PKA-stimulating
agents
Because intracellular cAMP levels are increased by b-AR
agonists, and increased intracellular cAMP levels induce HO-
1 via a PKA-dependent pathway (19), we tested whether an
activator of adenylate cyclase forskolin could induce HO-1
gene expression in RAW264.7 cells. Indeed, forskolin induced
HO-1 levels in a dose-dependent manner (1–30 lM) after 6 h
treatment (Fig. 2A). Following pretreatment with the PKA
inhibitor, H-89, HO-1 production was inhibited by forskolin
at 30 lM (Fig. 2B). H-89 also decreased isoproterenol-induced
HO-1 production, suggesting a PKA-dependent induction of
HO-1 gene expression in these cells (Fig. 2C).
3.3. Stimulation of HO-1 production via b1-adrenoceptors
To examine the role of b-adrenoceptors for the production
of HO-1, we used the speciﬁc antagonist propranolol. As
shown in Fig. 3A and B, isoproterenol eﬀectively induced
HO-1 levels and activity at 100 lM, and this was inhibited
by pretreatment with propranolol in a dose-dependent
Fig. 1. Eﬀect of isoproterenol on HO-1 production and activity in
RAW264.7 cells. Cells were treated with isoproterenol for 6 h at doses
from 1 to 200 lM (A), and at the dose of 100 lM for 2, 4, 6, 8 and 12 h
(B). HO-1 protein levels and activity were measured from isoprotere-
nol-treated cells as described in Section 2.
ig. 2. Induction of HO-1 production by isoproterenol via the
hosphokinase A (PKA) pathway. (A) Dose-dependent induction of
O-1 production by the adenylate cyclase activator forskolin (1, 5, 10,
0, 30 lM) in RAW264.7 cells. Cells were treated with forskolin for 6 h
t the doses indicated and western blot analysis was performed as
escribed in Section 2. (B) Prevention of forskolin-induced HO-1
roduction by pretreatment with the PKA inhibitor H-89. Cells were
retreated with H-89 (1, 10, 20 lM) for 1 h and then treated with
rskolin (30 lM) for 6 h. After treatment, protein was extracted from
e cells and HO-1 protein level was determined by western blot
nalysis. (C) Prevention of isoproterenol-induced HO-1 production by
retreatment with the PKA inhibitor H-89. Cells were pretreated with
KA inhibitors H-89 (10 lM) for 1 h and then treated with isopro-
renol (100 lM) for 6 h. Values in the graphs represent the densito-
etric data from three independent experiments (means ± S.E.M.).
\P < 0.01 compared with control; P < 0.05, P < 0.01 compared
ith forskolin or isoproterenol).
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tor involved in this. Isoproterenol-induced HO-1 production
was signiﬁcantly blocked by the speciﬁc b1-AR antagonist
metoprolol, but not by the b2-AR-speciﬁc antagonist butox-
amine (Fig. 3C and D). Fig. 3E shows that isoproterenol sig-
niﬁcantly increased the level of expression of b1-AR mRNA
even though the level expressed in resting cells was weak. On
the other hand, b2-AR mRNA levels were very low in control
or isoproterenol-treated cells. These results suggest that isopro-
terenol induced HO-1 gene expression through the b1-speciﬁc
adrenoceptor.
3.4. Protection of RAW264.7 from oxidative stress via HO-1
expression
As shown in Fig. 4A, isoproterenol protected RAW264.7
cells from GOX-induced cytotoxicity. When the cells were
treated with GOX for 6 h, the cells showed about 38% viabil-
ity, however the presence of isoproterenol signiﬁcantly in-
creased this to 60%. Pretreatment with propranolol, a b-AR
antagonist, abrogated this protective eﬀect. To verify that this
was mediated by HO-1, cells were preincubated with the HO-1
inhibitor ZnPP IX for 30 min before addition of isoproterenol.
Fig. 4B clearly shows that the eﬀect of isoproterenol was signif-
icantly inhibited by the presence of ZnPP IX, indicating that
HO-1 plays a role in protecting cells against GOX-induced in-
jury. Because it is well known that CO produced via HO-1
activity mainly contributes to its protective eﬀect, we investi-

















Fig. 3. Induction of HO-1 protein production and activity by isoproterenol via the b-adrenoceptor (AR). Propranolol, a b-AR antagonist, was
administered (1, 10, 20 lM) 1 h before treatment with 100 lM of isoproterenol. After 6 h (A) HO-1 protein and (B) enzyme activity levels were
detected as described in the Materials and Methods. (C) Involvement of b1- AR in isoproterenol-induced HO-1 gene expression. Cells were pretreated
with (C) the b1-AR antagonist metoprolol (1, 10 lM) or (D) the b2-AR antagonist butoxamine (1, 5, 10 lM) for 1 h and then treated with
isoproterenol for 6 h. Cells were then harvested for western blot analysis. Each bar represents the means ± S.E.M. of experiments (\\P < 0.01
compared with control, P < 0.01 compared with isoproterenol). (E) Detection of b1- or b2-AR mRNA in isoproterenol-treated RAW264.7 cells by
RT–PCR. Total RNA was extracted from the cells treated with isoproterenol (100 lM for 2 or 4 h). RT-PCR was performed as described in Section 2
and GAPDH was used as an internal standard. The data represent three separate experiments.
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dose-dependent manner, suggesting that isoproterenol-induced
HO-1 expression may exert a protective eﬀect through CO
activity. To further determine the protective eﬀect of isoprote-
renol on RAW264.7 cells from GOX, which is caused by iso-
proterenol-induced HO-1 gene expression, we performed
DNA fragmentation analysis for apoptosis. As shown in
Fig. 4C, GOX at 15 mU/mL eﬀectively induced DNA strand
breakage after 6 h. Isoproterenol blocked this GOX-induced
DNA laddering, however in the pretreatment of ZnPP IX, iso-
proterenol failed to prevent the cells from apoptosis. Propran-
olol, a b-AR antagonist, also inhibited the protective eﬀect of
isoproterenol (Fig. 4D). Thus, we suggest that isoproterenolinduces HO-1 gene expression through b adrenoceptors, espe-
cially the b1-adrenoceptor, and that isoproterenol-induced
HO-1 gene expression protects macrophage cells from oxida-
tive stress.4. Discussion
The aim of this study was to examine whether the induction
of HO-1 gene expression in macrophages by catecholamine is
associated with self-defense against oxidant stress. The adren-
ergic b1-receptor was clearly responsible for increased levels of
the stress-related enzyme HO-1, which is known to protect
Fig. 4. Protection of RAW264.7 from oxidative stress via isoproterenol-induced HO-1 gene expression. (A) Propranolol was administered at 50 lM,
1 h before treatment with 100 lM of isoproterenol and 15 mU of GOX. Six hours later, cell viability was determined by MTT assay. (B) ZnPP IX (1,
10 lM) was administered for 1 h, and then cells were treated with isoproterenol and GOX for 6 h. (C) Cells were treated with GOX with or without
RuCO for 6 h. Each bar represents the means ± S.E.M. of experiments. (\\P < 0.01 compared with control; P < 0.05, P < 0.01 compared with
GOX, §P < 0.05 compared with isoproterenol). (D,E) Protection of RAW264.7 cells from GOX-induced apoptosis by isoproterenol. RAW264.7 cells
were incubated with GOX (15 mU/ml) for 6 h with or without isoproterenol (100 lM). To determine the role of HO-1 or the involvement of
b-adrenoceptors in isoproterenol-mediated cell protection, cells were pretreated with ZnPP IX (D) or propranolol (E) 1 h before GOX or
isoproterenol administration, respectively. Treatment with 15 mU/mL GOX increased apoptosis 6 h after treatment. DNA laddering was visualized
using ethidium bromide staining under UV light.
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agonist, isoproterenol, as a source of catecholamines, because
among the natural catecholamines, norepinephrine is classiﬁed
as an a-agonist, epinephrine as an a- and b-agonist, and dopa-
mine as a weak a- and b-agonist. We expected that b2-AR
stimulation by isoproterenol might be involved in HO-1 gene
expression in the activation of macrophages, because b2-AR
is known to regulate immunological responses. However, the
results showed that b1-AR rather than b2-AR was involved
in the induction of HO-1 gene expression by isoproterenol.
b1-AR is coupled via G-proteins to the intracellular second
messenger system, adenylate cyclase. Thus, cAMP is the major
second messenger of b-AR activation. In line with this, the
adenylate cyclase activator forskolin increased HO-1 gene
expression. However, HO-1 gene induction by isoproterenol,
but not by forskolin, was inhibited by the nonselective b-
blocker, propranolol (data not shown), indicating that b-AR
activation was necessary. We speculate that increases inintracellular levels of cAMP may lead to activation of the
cAMP-dependent PKA. This was supported by our ﬁnding
that the PKA inhibitor H-89 inhibited the observed induction
of HO-1 after both isoproterenol and forskolin treatments,
suggesting that the PKA pathway plays a role in the induction
of HO-1 gene expression in macrophages. However, assuming
an increase of intracellular cAMP, it was reasonable to think
that activation of b2-adrenergic receptor could also induce
HO-1 gene expression. Unfortunately, this idea proved to be
wrong, because butoxamine, a selective b2-AR antagonist,
did not inhibit the induction of HO-1 gene expression by iso-
proterenol. To address this apparently puzzling question –
why activation of b2-adrenoceptor in RAW264.7 cells failed
to induce HO-1 gene expression even though it presumably in-
creased cAMP levels – we examined the mRNA expression of
b-adrenoceptor subtypes. Surprisingly, we found that the sub-
type activated by isoproterenol in RAW264.7 cells was pre-
dominantly b1, although both b1- and b2-adrenoceptors are
J. Sun et al. / FEBS Letters 579 (2005) 5494–5500 5499weakly expressed in resting cells. This ﬁnding is quite diﬀerent
from that for peritoneal macrophages, in which the b2-AR
subtype is mainly involved in the immune response [14].
On the other hand, HO-1 plays a fundamental role in cell
protection against oxidative stress [21]. HO-1 gene induction
appears to be part of a generalized cellular response that pro-
tects cells against oxidative stress and other toxic insults
[22,23]. We were interested in how macrophages can protect
themselves against oxidative stress, because macrophages are
widely distributed in varying numbers throughout most nor-
mal tissues and organs [24] and play an important role in
the regulation of the immune system [24–27]. Based on re-
ports that the introduction of oxidative stress leads to macro-
phage activation or to cytotoxic eﬀects such as apoptosis and
necrosis [27–29], we hypothesized that macrophages also have
antioxidant defense pathways involving catecholamines. The
term ‘‘macrophage’’ actually encompasses diﬀerent cell types
of monocytic origin that acquire particular properties as a
function of their environment. All macrophages express the
multicomponent enzyme NADPH oxidase and generate
superoxide to various extents. As macrophages are clearly in-
volved in both propagating inﬂammation through the phago-
cytosis of apoptotic and necrotic cells, a better understanding
of the possible mechanisms by which ROS or RNS may aﬀect
their response could have implications on the development of
anti-inﬂammatory therapeutics. Furthermore, macrophages
produce ROS such as O2 , H2O2 and
OH that contribute
not only to the pathogenesis of diseases such as inﬂammation
and atherosclerosis but also damage to themselves. Cells have
multiple defense systems against those ROS, and upon expo-
sure to ROS and electrophilic agents, murine peritoneal mac-
rophages induce stress proteins to protect themselves [30].
Induction of HO-1 gene expression and the related produc-
tion of CO in macrophages play essential roles in protecting
the cells against inﬂammation or oxidative stress [31–34].
Therefore, we focused on the role of catecholamines in mac-
rophages, because catecholamines are released not only from
sympathetic nerve terminals when the body is under stress,
but macrophages themselves produce catecholamines in re-
sponse to various stimulants that may aﬀect physiological
functions, especially antioxidant protection. Indeed, induction
of HO-1 gene expression by isoproterenol protected the cells
from glucose oxidase (GOX) treatment. GOX treatment in
the presence of glucose generates H2O2 [35,36], which causes
apoptotic cell death in many cells including the RAW264.7
cells studied here. RuCO, a CO donor, also protected the cells
from GOX treatment. It remains to be determined whether
CO is responsible for the isoproterenol-induced HO-1-medi-
ated protection from GOX. Although both a2 and b2-adreno-
ceptors are involved in immune regulatory functions, we
suggest that macrophages may have a novel role for self de-
fense mechanism by catecholamines via HO-1 expression
through b1-AR. Thus, it is possible that macrophages can
protect themselves from those amounts of nitric oxide they
produce to kill other microorganisms, because NO is a strong
inducer of HO-1 gene expression in many cells including
macrophages.
In conclusion, in this study we showed an upregulation of
HO-1 gene expression by the b adrenoceptor agonist, isoprote-
renol, via b1-AR activation and the PKA signaling pathway,
and demonstrated a protective eﬀect against oxidative stress
produced by GOX in RAW264.7 cells.Acknowledgement: This work was supported by Korea Research Foun-
dation (KRF-2004-005-E00058).References
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